Literature DB >> 14523912

Nucleic acid aptamers as tools and drugs: recent developments.

Martina Rimmele1.   

Abstract

Nucleic acid aptamers are molecules that bind to their ligands with high affinity and specificity. Unlike other functional nucleic acids such as antisense oligonucleotides, ribozymes, or siRNAs, aptamers almost never exert their effects on the genetic level. They manipulate their target molecules such as gene products or epitopes directly and site specifically, leaving nontargeted protein functions intact. In a similar way to antibodies, aptamers bind to many different kinds of target molecules with high specificity and can be made to order, but as a result of their different biochemical nature and size they can also be used complementary to antibodies. In some cases, aptamers might be more suitable or more specific than antibody approaches or small molecules, both as scientific and biotechnological tools and as therapeutic agents. Recent examples of characterization of aptamers as tools for scientific research to study regulatory circuits, as tools in diagnostic or biosensor development, and as therapeutic agents are discussed.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14523912     DOI: 10.1002/cbic.200300648

Source DB:  PubMed          Journal:  Chembiochem        ISSN: 1439-4227            Impact factor:   3.164


  22 in total

Review 1.  Translating nucleic acid aptamers to antithrombotic drugs in cardiovascular medicine.

Authors:  Thomas J Povsic; Bruce A Sullenger; Steven L Zelenkofske; Christopher P Rusconi; Richard C Becker
Journal:  J Cardiovasc Transl Res       Date:  2010-11-16       Impact factor: 4.132

2.  Comparative crystallization and preliminary X-ray diffraction studies of locked nucleic acid and RNA stems of a tenascin C-binding aptamer.

Authors:  Charlotte Förster; Arnd B E Brauer; Svenja Brode; Kathrin S Schmidt; Markus Perbandt; Arne Meyer; Wojciech Rypniewski; Christian Betzel; Jens Kurreck; Jens P Fürste; Volker A Erdmann
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2006-06-10

3.  Solution structure of an informationally complex high-affinity RNA aptamer to GTP.

Authors:  James M Carothers; Jonathan H Davis; James J Chou; Jack W Szostak
Journal:  RNA       Date:  2006-02-28       Impact factor: 4.942

Review 4.  Regulatory RNAs: charming gene management styles for synthetic biology applications.

Authors:  Jorge Vazquez-Anderson; Lydia M Contreras
Journal:  RNA Biol       Date:  2013-11-18       Impact factor: 4.652

5.  Rapid detection of natriuretic peptides by a microfluidic LabChip analyzer with DNA aptamers: Application of natriuretic peptide detection.

Authors:  Ming-Cheng Lin; Jiraporn Nawarak; Tai-Yuan Chen; Hsien-Yu Tsai; Jung-Feng Hsieh; Supachok Sinchaikul; Shui-Tein Chen
Journal:  Biomicrofluidics       Date:  2009-07-30       Impact factor: 2.800

6.  Application of locked nucleic acids to improve aptamer in vivo stability and targeting function.

Authors:  Kathrin S Schmidt; Sandra Borkowski; Jens Kurreck; Andrew W Stephens; Rolf Bald; Maren Hecht; Matthias Friebe; Ludger Dinkelborg; Volker A Erdmann
Journal:  Nucleic Acids Res       Date:  2004-10-27       Impact factor: 16.971

7.  Fluorescence assay based on aptamer-quantum dot binding to Bacillus thuringiensis spores.

Authors:  Milada Ikanovic; Walter E Rudzinski; John G Bruno; Amity Allman; Maria P Carrillo; Sulatha Dwarakanath; Suneetha Bhahdigadi; Poornima Rao; Johnathan L Kiel; Carrie J Andrews
Journal:  J Fluoresc       Date:  2007-01-31       Impact factor: 2.217

8.  A novel aptamer developed for breast cancer cell internalization.

Authors:  Kejing Zhang; Kwame Sefah; Lili Tang; Zilong Zhao; Guizhi Zhu; Mao Ye; Weijia Sun; Steve Goodison; Weihong Tan
Journal:  ChemMedChem       Date:  2011-12-14       Impact factor: 3.466

9.  Aptamer antagonists of myelin-derived inhibitors promote axon growth.

Authors:  Yuxuan Wang; Zin Z Khaing; Na Li; Brad Hall; Christine E Schmidt; Andrew D Ellington
Journal:  PLoS One       Date:  2010-03-16       Impact factor: 3.240

10.  Development of the anti-VEGF aptamer to a therapeutic agent for clinical ophthalmology.

Authors:  Cleber A Trujillo; Arthur A Nery; Janaína M Alves; Antonio H Martins; Henning Ulrich
Journal:  Clin Ophthalmol       Date:  2007-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.